Publicaties
Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine‑therapy. Doornhof KR, Van der Linden PD, Boeke GM, Willemsen AECAB, Daskapan A. Eur J Clin Pharmacol. 2023, Feb 9. doi: 10.1007/s00228-023-03466-8.